CLINICAL_TRIALS
trial_result
· 2022-07-14
Clinical Trial Update: Romidepsin Plus 3BNC117 Phase 2a Study [Phase 2]
Summary
Phase 2a study evaluating romidepsin plus 3BNC117 in HIV completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rockefeller University | Conditions: Human Immunodeficiency Virus (HIV) | Phase 2 | Status: COMPLETED | Results posted: 2022-07-14